KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Xenon Pharmaceuticals (XENE) Return on Sales: 2014-2025

Historic Return on Sales for Xenon Pharmaceuticals (XENE) over the last 9 years, with Mar 2025 value amounting to -15.67%.

  • Xenon Pharmaceuticals' Return on Sales was N/A to -15.67% in Q1 2025 from the same period last year, while for Mar 2025 it was -15.67%, marking a year-over-year change of. This contributed to the annual value of -13.29% for FY2022, which is 902.00% down from last year.
  • Xenon Pharmaceuticals' Return on Sales amounted to -15.67% in Q1 2025, which was down 81.74% from -8.62% recorded in Q3 2022.
  • In the past 5 years, Xenon Pharmaceuticals' Return on Sales ranged from a high of -1.26% in Q1 2021 and a low of -15.67% during Q1 2025.
  • In the last 1 years, Xenon Pharmaceuticals' Return on Sales had a median value of -15.67% in 2025 and averaged -15.67%.
  • In the last 5 years, Xenon Pharmaceuticals' Return on Sales skyrocketed by 153bps in 2021 and then plummeted by 458bps in 2022.
  • Over the past 3 years, Xenon Pharmaceuticals' Return on Sales (Quarterly) stood at -5.33% in 2021, then slumped by 458bps to -8.62% in 2022, then reached -15.67% in 2025.
  • Its Return on Sales was -15.67% in Q1 2025, compared to -8.62% in Q3 2022 and -5.24% in Q2 2022.